| Value | ₹0.44 Cr |
|---|
BSE filing, NSE: MANINFRA. Summary written from the filing by ALFA Finder's alert engine.
Man Infraconstruction Ltd: key numbers
- Share price
- ₹111.01
- Market cap
- ₹4,481 Cr
- Revenue (annual)
- ₹630.5 Cr
- Net profit (annual)
- ₹200.6 Cr
- P/E (TTM)
- 20.7×Sector 31.3×
- Promoter holding
- 62.52%+0.00% QoQ
- FII holding
- 1.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Man Infraconstruction Ltd
All →Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Man Infraconstruction Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹266 Cr (+57% YoY), PAT ₹62.8 Cr (+14%); H1 revenue ₹484 Cr (+30%), PAT ₹134.4 Cr (+21%). Godrej Marine Lines deal unlocks ₹6,000+ Cr GDV.
Man Infraconstruction Results Update
Man Infraconstruction reported consolidated PAT of ₹63 crores in Q2FY27, up 14% YoY, and ₹134 crores for H1FY27, up 21%. Revenue and sales momentum remained strong across its EPC and real estate verticals.
Man Infraconstruction Q2 FY27 Results: Net Profit ₹65.2 Cr, Up 8.7% YoY
Man Infraconstruction Ltd reported revenue from operations of ₹266 Cr (+57.2% YoY) and net profit of ₹65.2 Cr (+8.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.2 Cr · +8.7% YoY
Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 1,50,000 equity shares on 28 October 2026 at an average price of Rs 111.64. Cumulative shares bought back now total 1,03,10,000.
- Value
- ₹1.67 Cr
Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 42,000 equity shares on the NSE on October 26, 2026, at an average price of Rs. 102.4262. The cumulative buyback total stands at 1,00,55,000 shares.
- Value
- ₹0.43 Cr
Other capital structure change announcements
All →Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 54,455 equity shares via Emkay Global on October 29, 2026 at an average of ₹263.76. Cumulative buyback stands at 24,10,906 shares under the ongoing open-market programme.
- Value
- ₹1.44 Cr
63 Moons Technologies Capital Structure Change
63SATS, a subsidiary of 63 Moons, signed a warrant subscription deal with BCCL. BCCL pays Rs 6.5 Crore upfront, deferring dilution until warrant exercise.
- Value
- ₹6.50 Cr
63 Moons Technologies Capital Structure Change
Material subsidiary 63SATS Cybertech signed a warrant subscription agreement with Bennett Coleman for 65 warrants. Aggregate warrant value is Rs.65 Crore, with 10% (Rs.6.5 Crore) payable upfront.
- Value
- ₹65.00 Cr
Otco International Capital Structure Change
OTCO International Ltd fixed 06 November 2026 as the record date for consolidating 5 equity shares of Rs.2 face value into 1 share of Rs.10 face value. The consolidation was approved by shareholders at the AGM held 17 September 2026.
Meesho Capital Structure Change
Meesho will invest up to USD 1 lakh in cash, in tranches, in its wholly owned US subsidiary. Its 100% holding stays unchanged, worth about ₹0.01 Crore.
- Value
- ₹0.01 Cr
Crescentis Capital Capital Structure Change
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
- Value
- ₹79.62 Cr